Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer.
Tie J, Cohen JD, Wang Y, Christie M, Simons K, Lee M, Wong R, Kosmider S, Ananda S, McKendrick J, Lee B, Cho JH, Faragher I, Jones IT, Ptak J, Schaeffer MJ, Silliman N, Dobbyn L, Li L, Tomasetti C, Papadopoulos N, Kinzler KW, Vogelstein B, Gibbs P.
JAMA Oncol. 2019 Dec 1;5(12):1710-1717. doi: 10.1001/jamaoncol.2019.3616.
The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity.
Lin J, Xia L, Oyang L, Liang J, Tan S, Wu N, Yi P, Pan Q, Rao S, Han Y, Tang Y, Su M, Luo X, Yang Y, Chen X, Yang L, Zhou Y, Liao Q.
Oncogene. 2022 Feb;41(7):1024-1039. doi: 10.1038/s41388-021-02148-y. Epub 2022 Jan 8.
Management of malignant colon polyps: current status and controversies.
Aarons CB, Shanmugan S, Bleier JI.
World J Gastroenterol. 2014 Nov 21;20(43):16178-83. doi: 10.3748/wjg.v20.i43.16178.
The Role of Tumor Location on Endoscopic and Surgical Management of Malignant Colon Polyps.
Weaver L, Boatman S, Kohn J, Mott SL, Gaertner WB, Madoff RD, Melton GB, Shaukat A, Hassan I, Goffredo P.
Ann Surg Oncol. 2024 Oct;31(10):6452-6460. doi: 10.1245/s10434-024-15931-4. Epub 2024 Jul 30.
HOXD13 promotes the malignant progression of colon cancer by upregulating PTPRN2.
Yin J, Guo Y.
Cancer Med. 2021 Aug;10(16):5524-5533. doi: 10.1002/cam4.4078. Epub 2021 Jul 17.
Role of Tumor Specific niche in Colon Cancer Progression and Emerging Therapies by Targeting Tumor Microenvironment.
Banerjee A, Chabria Y, Kanna N R R, Gopi J, Rowlo P, Sun XF, Pathak S.
Adv Exp Med Biol. 2021;1341:177-192. doi: 10.1007/5584_2019_355.
Mechanical signatures of human colon cancers.
Lopez-Crapez E, Costa L, Tosato G, Ramos J, Mazard T, Guiramand J, Thierry A, Colinge J, Milhiet PE, Bénistant C.
Sci Rep. 2022 Jul 21;12(1):12475. doi: 10.1038/s41598-022-16669-3.
Multifaceted Interpretation of Colon Cancer Stem Cells.
Hatano Y, Fukuda S, Hisamatsu K, Hirata A, Hara A, Tomita H.
Int J Mol Sci. 2017 Jul 5;18(7):1446. doi: 10.3390/ijms18071446.
Exosomes derived from microRNA-129-5p-modified tumor cells selectively enhanced suppressive effect in malignant behaviors of homologous colon cancer cells.
Ji Y, Ji J, Yin H, Chen X, Zhao P, Lu H, Wang T.
Bioengineered. 2021 Dec;12(2):12148-12156. doi: 10.1080/21655979.2021.2004981.
A case of a mixed adenoneuroendocrine tumor of the colon.
Silva JRD, Pinho RT, Furtado A.
Rev Esp Enferm Dig. 2017 Sep;109(9):673. doi: 10.17235/reed.2017.5008/2017.
